Explore
13D/13G Activist Filings
118,859 resultsSome filings may show "N/A" for ticker if the subject is a private fund, SPAC, or unlisted security.
| Filed ↓ | Ticker | Company | Filer | Form | % Owned | Shares |
|---|---|---|---|---|---|---|
| Feb 6, 2026 | ETHM | Dynamix Corp | Meteora Capital, LLC | 13G | 14.9% | 2.5M |
| Feb 6, 2026 | DELL | Dell Technologies Inc. | Michael S. Dell | 13G/A | 45.7% | 265.7M |
| Feb 6, 2026 | SLP | Simulations Plus, Inc. | First Light Asset Management, LLC | 13G | 13.2% | 2.6M |
| Feb 6, 2026 | UUU | UNIVERSAL SAFETY PRODUCTS, INC. | Hyperscale Data, Inc. | 13D/A | 17.4% | 472K |
| Feb 6, 2026 | DMAC | DiaMedica Therapeutics Inc. | TRILL AB | 13G/A | 16.9% | 8.8M |
| Feb 6, 2026 | EQ | EQUILLIUM, INC. | JANUS HENDERSON GROUP PLC | 13G/A | 10.0% | 6.1M |
| Feb 6, 2026 | MAZE | MAZE THERAPEUTICS, INC. | GV 2019, L.P. | 13G/A | 1.6% | 784K |
| Feb 6, 2026 | RLMD | RELMADA THERAPEUTICS, INC. | JANUS HENDERSON GROUP PLC | 13G | 10.1% | 7.4M |
| Feb 6, 2026 | BHVN | BIOHAVEN LTD. | JANUS HENDERSON GROUP PLC | 13G/A | 12.7% | 16.8M |
| Feb 6, 2026 | MPX | Marine Products Corporation | Gary W. Rollins | 13D/A | 8.7% | 3.0M |
| Feb 6, 2026 | BMEA | Biomea Fusion, Inc. | Rainer M. Erdtmann | 13G/A | 3.9% | 2.8M |
| Feb 6, 2026 | ALEC | Alector, Inc. | Arnon Rosenthal | 13G/A | 7.4% | 8.2M |
| Feb 6, 2026 | GBIO | Generation Bio Co. | Baselake Partners, LP | 13G | 5.2% | 350K |
| Feb 6, 2026 | LONA | LeonaBio, Inc. f.k.a. Athira Pharma, Inc. | Baselake Partners, LP | 13G/A | 1.9% | 76K |
| Feb 6, 2026 | NEUP | Neuphoria Therapeutics Inc. | Baselake Partners, LP | 13G/A | 4.1% | 222K |
| Feb 6, 2026 | JANX | Janux Therapeutics, Inc. | Prosight Management, LP | 13G | 5.2% | 3.2M |
| Feb 6, 2026 | LB | LandBridge Co LLC | Morgan Stanley | 13G/A | 8.3% | 2.1M |
| Feb 6, 2026 | BKV | BKV CORPORATION | Banpu Public Company Limited | 13D | 67.7% | 69.2M |
| Feb 6, 2026 | ARHS | Arhaus Inc | Wasatch Advisors LP | 13G/A | 15.5% | 8.4M |
| Feb 6, 2026 | KALA | KALA BIO, Inc. | David E. Lazar | 13D | 5.2% | 49.5M |
| Feb 6, 2026 | NRG | NRG ENERGY, INC. | Lightning Power Holdings, LLC | 13G | 8.9% | 19.0M |
| Feb 6, 2026 | VTYX | Ventyx Biosciences, Inc. | Morgan Stanley | 13G/A | 0.3% | 237K |
| Feb 6, 2026 | TNGX | Tango Therapeutics, Inc. | Farallon Capital Partners, L.P. | 13G/A | 1.6% | 2.2M |
| Feb 6, 2026 | GSIT | GSI Technology, Inc. | Lee-Lean Shu | 13G/A | 9.8% | 3.7M |
| Feb 6, 2026 | IOBT | IO Biotech, Inc. | Point72 Asset Management, L.P. | 13G | 5.6% | 4.0M |
| Feb 6, 2026 | GLXY | Galaxy Digital Inc. | Michael E. Novogratz | 13G/A | 49.9% | 192.2M |
| Feb 6, 2026 | PTGX | Protagonist Therapeutics, Inc. | Farallon Capital Partners, L.P. | 13G/A | 0.5% | 283K |
| Feb 6, 2026 | SMTI | Sanara MedTech Inc. | BAIRD TRUST Co | 13G | 8.5% | 760K |
| Feb 6, 2026 | CMCO | Columbus McKinnon Corporation | CD&R XII KEYSTONE HOLDINGS, L.P. | 13D | 42.5% | 21.2M |
| Feb 6, 2026 | N/A | Coller Secondaries Private Equity Opportunities Fund | PRUDENTIAL MERGED RETIREMENT PLAN | 13G/A | 21.1% | 29.1M |
| Feb 6, 2026 | RJET | REPUBLIC AIRWAYS HOLDINGS INC. | Owl Creek Asset Management, L.P. | 13G | 8.8% | 4.1M |
| Feb 6, 2026 | ACOG | Alpha Cognition Inc. | Opaleye Management Inc. | 13G | 9.5% | 2.1M |
| Feb 6, 2026 | BIRK | Birkenstock Holding plc | BK LC Lux MidCo S.a r.l. | 13G/A | 54.1% | 99.4M |
| Feb 6, 2026 | SRI | STONERIDGE INC | 22NW Fund, LP | 13D | 8.2% | 2.3M |
| Feb 6, 2026 | VCRM | Vanguard Municipal Bond Funds | KARPUS MANAGEMENT, INC. | 13G/A | 4.7% | 598K |
| Feb 6, 2026 | N/A | SC II Acquisition Corp. | KARPUS MANAGEMENT, INC. | 13G | 12.0% | 3.0M |
| Feb 6, 2026 | KVAC | Keen Vision Acquisition Corp. | KARPUS MANAGEMENT, INC. | 13G/A | 3.2% | 294K |
| Feb 6, 2026 | THAR | THARIMMUNE, INC. | Broadridge Financial Solutions, Inc. | 13G | 10.0% | 4.2M |
| Feb 6, 2026 | PRQR | ProQR Therapeutics N.V. | Van Herk Investments B.V. | 13D/A | 14.6% | 15.4M |
| Feb 6, 2026 | PMN | ProMIS Neurosciences Inc. | Deep Track Capital, LP | 13G | 10.0% | 903K |
| Feb 6, 2026 | DIBS | 1stdibs.com, Inc. | Philotimo Fund, LP | 13G | 3.3% | 1.2M |
| Feb 6, 2026 | N/A | Music Licensing, Inc. | Glendon L. Hudson | 13D | 5.2% | 260 |
| Feb 6, 2026 | RFEM | FIRST TRUST EXCHANGE-TRADED FUND III | Robert W. Baird & Co. Inc | 13G/A | 6.9% | 45K |
| Feb 6, 2026 | SBRA | Sabra Health Care REIT, Inc. | PRINCIPAL REAL ESTATE INVESTORS LLC | 13G/A | 8.6% | 21.3M |
| Feb 6, 2026 | FDM | FIRST TRUST EXCHANGE-TRADED FUND | Robert W. Baird & Co. Inc | 13G/A | 5.1% | 138K |
| Feb 6, 2026 | IVT | InvenTrust Properties Corp. | PRINCIPAL REAL ESTATE INVESTORS LLC | 13G/A | 5.9% | 4.6M |
| Feb 6, 2026 | KYTX | Kyverna Therapeutics, Inc. | Westlake BioPartners Fund I, L.P. ("Westlake Fund I") | 13G/A | 6.3% | 3.8M |
| Feb 6, 2026 | HEI.A | HEICO CORP | PRINCIPAL GLOBAL INVESTORS | 13G/A | 10.6% | 8.9M |
| Feb 6, 2026 | APPF | APPFOLIO INC | PRINCIPAL GLOBAL INVESTORS | 13G | 5.1% | 1.2M |
| Feb 6, 2026 | AHR | American Healthcare REIT, Inc. | PRINCIPAL REAL ESTATE INVESTORS, LLC | 13G/A | 3.4% | 6.3M |